300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Film
Retail
Payments
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Poland
Oman
Puerto Rico
Cameroon
Guernsey
Colombia
China
Armenia
Costa Rica
Kenya
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Morocco
Seychelles
Paraguay
Botswana
South Africa
Canada
Ireland
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Europe
Qatar
Argentina
Angola
Cyprus
Barbados
Belgium
Bangladesh
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Faroe Islands
Jersey
Ecuador
Bahrain
Bolivia
Estonia
Belize
Algeria
Italy
Belarus
Finland
Bahamas
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Chile
Ukraine
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
C-Mer Eye Care Holdings, VC Fund

C-Mer Eye Care Holdings

VC Fund

Central, Hong Kong

C-Mer Eye Care Holdings is a VC fund in Central focused on Laser and Enterprise. C-Mer Eye Care Holdings is engaged in the provision of ophthalmic services. They offer treatments and services for cataract, glaucoma, and strabismus, as well as for eye diseases such as corneal and vitreoretinal diseases.

Total investments:
2
Last investment:
Lead investor:
50%

Last updated:

Industries C-Mer Eye Care Holdings invests in

LaserEnterpriseHealth CareMedical DeviceClinical Trials

Stages C-Mer Eye Care Holdings invests in

Series BVenture - Series Unknown

Countries C-Mer Eye Care Holdings invests in

ChinaIsrael

Contacts

NameEmailPhoneSocials
Dennis Lam Dennis Lam

Sign up to unlock verified contacts

Unlock Contacts

Investment Focus

Industry

  • Laser 1 (50%)
  • Enterprise 1 (50%)
  • Health Care 1 (50%)
  • Medical Device 1 (50%)
  • Clinical Trials 1 (50%)

Stage

  • Series B 1 (50%)
  • Venture - Series Unknown 1 (50%)

Country

  • China 1 (50%)
  • Israel 1 (50%)

Team

NameTitleInvestmentsLinksEmail
Dennis Lam
Dennis Lam Founder, Chairman, Executive Director & CEO
Founder, Chairman, Executive Director & CEO Total investments: 1 Find email

Investments

CompanyDescriptionRoundLinks
Beijing Zhongyin Technology Co., Ltd. is a professional enterprise engaged in the research and development of clinical genetic diagnosis, prevention and gene therapy for hereditary eye diseases. The company's clinical genetic diagnosis platform for hereditary eye diseases can provide fast, accurate, reliable and professional clinical geneticdiagnosis services for hereditary ophthalmology patients. Venture - Series Unknown / May 25, 2026
BELKIN Vision develops a laser device to assist healthcare professionals in treating glaucoma. It offers non-invasive, non-contact, instantaneous, painless, and automated devices offering laser therapy and is aimed at promoting accessibility to first-line drop-less glaucoma care by allowing any ophthalmologist to treat patients. $12.3M / Series B / Jul 21, 2020

Co-Investors

BioLight Israeli Life Sciences Investments BioLight Israeli Life Sciences Investments 1 deal together
CR-CP Life Science Fund 1 deal together Rimonci Capital Rimonci Capital 1 deal together
Santen Ventures 1 deal together

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Film
Retail
Payments
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Poland
Oman
Puerto Rico
Cameroon
Guernsey
Colombia
China
Armenia
Costa Rica
Kenya
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Morocco
Seychelles
Paraguay
Botswana
South Africa
Canada
Ireland
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Europe
Qatar
Argentina
Angola
Cyprus
Barbados
Belgium
Bangladesh
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Faroe Islands
Jersey
Ecuador
Bahrain
Bolivia
Estonia
Belize
Algeria
Italy
Belarus
Finland
Bahamas
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Chile
Ukraine
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does C-Mer Eye Care Holdings invest in?

C-Mer Eye Care Holdings invests primarily in Laser, Enterprise and Health Care startups, most often at Series B and Venture - Series Unknown stage. Most of the 2 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

How do I contact C-Mer Eye Care Holdings?

Public channels for C-Mer Eye Care Holdings include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at C-Mer Eye Care Holdings?

The team at C-Mer Eye Care Holdings includes Dennis Lam (Founder, Chairman, Executive Director & CEO). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
C-Mer Eye Care Holdings C-Mer Eye Care Holdings Find emails